II.1)
Scope of the procurement
An Instrument for Genetic Analysis
Reference number:
PR22-018
38000000
-
Laboratory, optical and precision equipments (excl. glasses)
Supplies
II.1.4)
Short description
NIBRT is looking to acquire an instrument for sequencing and fragment analysis of genetic material. The desired solution is one that is designed for low to medium throughput activities and which enables simplified operation by users of various experience levels. The desired solution will be used to support different activities, therefore, the potential for self-contained cartridge type operation, or similar, is highly attractive to enable users to generate information quickly in a project specific manner.
II.1.5)
Estimated total value
Value excluding VAT: 300000.00
EUR
II.1.6)
Information about lots
This contract is divided into lots:
no
II.2.2)
Additional CPV code(s)
38000000
-
Laboratory, optical and precision equipments (excl. glasses)
II.2.3)
Place of performance
NUTS code:
IE061 -
Dublin
II.2.4)
Description of the procurement
NIBRT is looking to acquire an instrument for sequencing and fragment analysis of genetic material. The desired solution is one that is designed for low to medium throughput activities and which enables simplified operation by users of various experience levels. The desired solution will be used to support different activities, therefore, the potential for self-contained cartridge type operation, or similar, is highly attractive to enable users to generate information quickly in a project specific manner.
Price is not the only award criterion and all criteria are stated only in the procurement documents
Value excluding VAT: 300000.00
EUR
II.2.7)
Duration of the contract, framework agreement or dynamic purchasing system
Duration in months:
12
This contract is subject to renewal:
no
II.2.10)
Information about variants
Variants will be accepted:
no
II.2.11)
Information about options
Options:
no
II.2.13)
Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
no